Hello Friends 👋

In this special episode of The Incubator Podcast, Ben sits down with Dr. Jay Greenspan, Dr. Kevin Dysart, and Yari Payne, key organizers of the upcoming Hot Topics in Neonatology Conference. This celebrated conference, renowned for over 40 years, will take place from December 9–11 at the Gaylord National in National Harbor, Maryland. Attendees can look forward to exploring groundbreaking research and innovations in neonatology, with sessions covering topics like artificial intelligence, bronchopulmonary dysplasia, oxygen management, and much more.

Listeners will gain insight into the conference's "Green and Rotten Apples" sessions, where emerging therapies are critically examined, and a glimpse into the collaborative process that brings international expertise to the event. The conference offers invaluable opportunities for networking, fostering connections between early-career professionals and seasoned leaders in the field. For Incubator listeners, there’s an exclusive 10% discount on registration with the code IncubatorPod at checkout. Don’t miss this chance to join a global community of neonatal experts and dive into the latest research and discussions shaping neonatal care.

----

Learn more about Hot Topics here: https://hottopicsinneonatology.nemours.org/

Grab your special discount when you register whether in person or online:

----

The transcript of today's episode can be found below 👇

Ben Courchia MD (00:00.352)

Hello, everybody. Welcome back to the incubator podcast. We are back with a special episode with the organizing committee from the upcoming conference, Hot Topics in Neonatology. I think we are all very much familiar with this amazing conference, and it is my pleasure to have on the podcast some of the members of the organizing committee. I'm going to introduce them right now. First and foremost, we have Dr. Jay Greenspan. Jay, thank you so much for making the time to come on. You're joined by K.

Jay Greenspan (00:25.582)

Thanks, Pat. Thank you.

Ben Courchia MD (00:29.58)

Kevin Dysart, Kevin, welcome to the show. And even though she's here reluctantly, Yari Payne is here with us, another crucial member of the team. Yari, thank you for making the time to come on the podcast with us.

Kevin Dysart (00:32.464)

Thanks for having us.

Yari (00:42.871)

Thank you.

Ben Courchia MD (00:44.386)

We're very excited at the incubator about the upcoming Hot Topics Conference. For those of our listeners who may not be familiar as to when this is going to take place, the upcoming Hot Topics Conference will take place in December, between December 9 and 11. It will be taking place in National Harbor, Maryland. And it is a hybrid conference. There's an opportunity to attend in person and to attend virtually.

At the incubator, we're very excited that we will be there in attendance providing coverage of the conference for the listeners and the audience members who may not have the privilege of being there. And so it's a great opportunity for us today to discuss a little bit what we're looking forward to and some of the exciting aspects of the conference. Jay, I wanted to start with you maybe, and if you could possibly tell us a little bit about the long...

the long history of Hot Topics. mean, this is a conference that has a pretty impressive tradition of excellence, and it's always an extremely well attended conference. Can you tell us a little bit, some of your pearls from the years you've attended and organized the conference?

Jay Greenspan (01:51.918)

Yeah.

Yeah. Well, thanks, Ben. It's a great honor to be on this podcast. As you know, I'm an avid listener. So Hot Topics is decades old. It's over 30 years old. It's started by Jerry Lucy, who's part of, with the team from Vermont Oxford back in the eighties. I remember going as a fellow and then a junior attending. And in Jerry's vision, it was to bring the best research.

the hottest topics, the biggest controversies to a group led by the senior authors of those papers to talk about the impact or future impact of these studies. And so we saw all sorts of stuff from the beginnings of surfactant to nitric to cooling and all that was first introduced at Hot Topics in Neonatology. And we would always send somebody or a couple of people from each group to get the hottest and bring it back.

Ben Courchia MD (02:52.801)

Yeah.

Jay Greenspan (02:53.342)

About a little over a dozen years ago, Jerry was looking to retire and he reached out to Nemours to purchase the conference. And there was sort of a separation between the conference in Vermont Oxford at that time. you know, being at Nemours, I was elected as the neonatologist to help run it with Jerry and Jerry stayed on for a couple of years.

And I hope it was a smooth transition, but we've always tried to keep it in Jerry's vision. So Jerry always had a very academic approach. He was very much into the statistics and making sure the statistics were solid. He was into international, making it international. felt that was very important. And that's why it's basically in Washington, DC. We're right outside Washington, but we will be back in Washington next year. And he felt it was important for the international community to come to.

Washington DC, maybe meet with the NIH, et cetera. And he warned me, do not move that conference from Washington DC. So we continued and I learned very quickly that I needed help. And that help came in the form of Haresh Kirpalani, who's one of best person, best neonatologist, best leaders, so well connected. And he really has been the...

the person running the content of the conference for the last dozen years. And, you know, we needed help. It's a lot of work. We brought on Kevin and Liz Foglia. It's such a great team. this year, Jochen has joined us. And it allows us to really have our fingers in all the where the hot topics are. So we meet all the time and try to go over it and make it the best conference to bring the research directly to

Ben Courchia MD (04:21.313)

Yeah.

Jay Greenspan (04:38.294)

the international community.

Ben Courchia MD (04:40.64)

Yeah, I mean, I think it's so important to mention Gerald Lucy in this conversation. think for the people who are not familiar with who he is, he sadly passed away in 2017, but he's at the forefront of all the publications and the data that came out on Bela Rubin and phototherapy, especially in the US. And I think that when you read that story, it's so fascinating because you hear a lot of the things resonating with what you're describing. First of all, his willingness to always have trainees from around the world working with him. This international aspect that you mentioned was

Kevin Dysart (04:58.064)

Thank

Ben Courchia MD (05:10.4)

near and dear to him, not just with hot topics, but with his practice as well. And then I think overall this general curiosity, because the way when I was reading his original papers, you can see that this was someone that was always curious about, tell me more about this and would investigate. And it feels like this is something we're seeing through the conference, through the agenda, with the topics that are really always the topics we are all talking about that are not just controversial, but that pique our interest. So I think

I think that's kind neat that this tradition really has been here all this time. Thank you, Jay. Kevin, I'm going to turn to you and maybe ask you for this upcoming year, can you tell us a little bit about how the conference is structured and specific sessions that you think are really going to be popular with attendees and other potential interest groups?

Kevin Dysart (06:03.63)

Yeah, I really wish Liz and Harris could be here because as Jay said, they spend a great portion of their time and throughout the year putting the conference together, connecting with the people who will be the investigators. I think one of the best parts of the conference is getting to see those people who have conducted the research, maybe spent five, seven years of their life committed to this effort. And this is the moment where it crystallizes together.

For this year, I'm really interested in some of the green rotten apple sessions. Okay.

Ben Courchia MD (06:35.81)

So let's talk about that for a second because in the agenda, people might notice that there are sessions called Green and Rotten Apples. What is that title? Tell us a little bit about what is that referencing?

Kevin Dysart (06:48.75)

Yeah, I mean, think Jay probably has a perspective on it as well, inheriting it from Jerry, but I think the intention is exactly that. this something we should adopt into our clinical practice? Is this something we should take off with and rapidly incorporate? Or is this something that really isn't ready for prime time or something we should turn away from? so Jay, I don't know if you want to make a comment about how Jerry came to the name.

Jay Greenspan (07:12.814)

Yeah, exactly. Yeah, was exactly that. mean, it was, let's present the newest sort of the phase two research to say, you know, is this cell therapy or this nitric oxide therapy or this surfactant really going to work or is it going to be a rotten apple? And we've had a few rotten apples. We've had a lot of green apples. It's sort of amazing when you look back when I first.

went there in the late 80s and some of the things that were green apples, do you think surfactants really going to work this time? And it became like a mainstay. So that's where we put the phase two, not the studies where we're trying to fine tune something that we already know about, nutrition, et cetera. It's really for the studies that are not quite ready to pronounce as standard.

Ben Courchia MD (08:06.05)

Yeah. Yeah, I mean, there's a few sessions that are very interesting. think on the first day of the conference, you have a few sessions on artificial intelligence. I think that is really putting your finger right there on the pulse of the community, trying to figure out, this something that, like you said, is this something that we're going to implement in practice soon? Is there a real use for us on a day-to-day basis? There are some other sessions on increased alveolar volume and lung diffusion capacity.

in former preterm infants. There's a few on human milk fortification. So lots of very interesting subjects that are definitely hot topics. No pun intended.

Kevin Dysart (08:45.412)

Yeah, I have the privilege of being the moderator for that session with the artificial intelligence and Cindy McEvoy talking about her work around, know, continuous positive airway pressure and extra weeks there. So artificial intelligence is also a passion of mine. So like I've gotten to know Brynn Sullivan and Kristen Beam and we, you have a similar interest and joined a similar group. So I'm really excited for what they have to say to hear what Kristen has to say about is it friend or foe? Where is it going to?

Ben Courchia MD (08:51.029)

Yeah.

Kevin Dysart (09:15.684)

How is it going to change us? If it is going to change us? can we get predictions that help us get to bedside sooner and make a difference?

Ben Courchia MD (09:23.574)

Yeah. And if anything, maybe even outline the path as to what the future will look like based on the extensive work she's done.

Kevin Dysart (09:30.221)

Absolutely.

Absolutely.

Ben Courchia MD (09:34.178)

I want to touch on something you guys mentioned. think that it's one of these conferences, Hot Topics is one of these conferences where you look at the agenda and you can really see that there's been a tremendous amount of work that has been done in curating the speakers and the topics. How much work goes into selecting the incredible faculty that is listed on the agenda and the topics themselves? It seems like it would be months and months of ongoing conversation with this impressive team.

Kevin Dysart (10:04.496)

It really starts already now for 2025 as we're sitting here in 2024. We, Yari has already sent out emails saying, all right, when we're at the conference, we usually have a lunch and we invite people to it to give us ideas. And, you highlighted the artificial intelligence sessions that we've added to green and rotten apples. And that was a suggestion from last year during the lunch period. Maybe we should add that. And then again, to highlight the work that Liz and Harris do.

We have virtual sessions where, again, people that are well respected, well established, have worked for years, and younger people give us ideas as to what to invite and who's doing the work. And Jay highlighted earlier that Harris is incredibly well connected internationally. And so he really has his finger on the pulse with Liz of what's happening, who's doing what. So Jay, I don't know if you have anything else to say about how we get there.

Jay Greenspan (10:59.168)

Yeah, exactly. you know, we go to conferences, we, we, we, we're involved with the research networks. So we know what sort of coming up. We, we, we poke the folks to say, do you think you're going to have data by next December? And, you know, usually they know sometimes they're guessing occasionally we've had a present saying we don't have the data yet, but this is what we expect to see. Sometimes we get them as in last year when they were just published in the New England Journal that

That day actually we had one. And so there's a little bit of luck up there, but we really spent a lot of time trying to keep our hand on the pulse internationally. So we have contacts in New Zealand and Australia and all throughout Europe and third world countries. And actually interestingly, some of the greatest research presentations we've had in the last couple of years has come from the international third world country.

discussions, okay, group care was the one that came up. And we're actually bringing that back again this year because it's, been, you know, so such a hot issue. So we really try to keep our finger in the pulse. What's really cool about hot topics is it's got a great reputation. So if we ask an investigator, they almost always say yes, they'd be honored to come. And, and the other thing is that they often reach out to us and say, we got one for you, you know, so that's really cool too. I put that, that, you know, that's all her Russian Liz.

Ben Courchia MD (12:15.606)

That's nice.

Ben Courchia MD (12:21.247)

huh. Yeah.

Jay Greenspan (12:25.142)

And Jochen now is really also very well known and they have the finger on the pulses of their particular network, so it's been great.

Ben Courchia MD (12:34.754)

I wanted to maybe segue into what we're just talking about in terms of the curation and really mention how this conference can potentially be so beneficial for any provider at any level of training or at any level of their career. Because I think that on the one hand, a lot of the topics provide a tremendous overview as the state of the evidence in various subjects. for the early career neonatologist and providers and the maybe trainees,

It seems like an amazing opportunity to go to a venue that is populated by some of the brightest minds of our field and some of the most influential researchers in neonatology. Can you tell us a little bit in previous years how this networking opportunity, and I hate the word networking because I like the idea of more meaningful connections, what these connections have looked like for the attendees who are at Hot Topics when they get to interact with the

Haresh Kirpalani of the world, the Rich Polin and so on and so forth.

Jay Greenspan (13:37.174)

You know, we've really valued that and that's been historic from Jerry. So Jerry always felt that the, you know, the senior authors, we like junior authors too, but the senior authors type will come and talk to the junior faculty. We have a session on Tuesday evening where young faculty, young fellows and young neonatologists can get together with the senior faculty and just have, you know, a few drinks and appetizers. We think that's incredibly important. I mean,

look, what you guys do on the incubator podcast is near and dear to our hearts because it's getting, you know, we all practice medicine. There's unwarranted variation in how we practice. And what we're really trying to do at this conference and what you guys are trying to do is bring the evidence as close to the people that care for the babies as possible and discuss it and say, you know, should we change the way we manage the PDA? Should we change the way we manage skin? And, you know, you know,

some of the lessons learned from your podcast, you know, we were talking about feeble hemoglobin changes just because of your recent episode on transfusions just today. And I think it's just so important because it used to be years before you would get data to the baby. And so our goal is to have these discussions be rich, allow people to, you know, talk to the people who are in the trenches in the research, including these senior folks, and also frankly get advice on how they can get involved.

So it's, you know, it is virtual conference, but there's so much value to coming together in, in person and meeting, you know, Dr. Bancalari or Dr. Polin or, Dr. Martin and these guys, you know, wrote the books and they have the advice and,

Ben Courchia MD (15:19.027)

It's a surreal experience, especially if you're a young faculty and you find yourself very sometimes by accident in the middle of these conversations and you're like, I'm in the middle of a conversation between Ben Kalari Poll and what am I doing here? But it is the coolest feeling in the world. So I think for that alone, hybrid can go to hell. It's in person is the way to go.

Jay Greenspan (15:33.619)

Yes.

Kevin Dysart (15:34.448)

Yeah, 100 % it is.

Jay Greenspan (15:40.395)

Thank you.

Kevin Dysart (15:41.346)

Yeah, I've had the great fortune of knowing Jay for a very long time and being mentored by him and then being mentored by Harris as well. And I can remember some of those exact experiences, Ben, where it was like, you know, Jay knows everybody and Harris knows everybody and I'm standing there and I'm like, I definitely don't belong here. Like, I should go. Let me just sneak away. But it is an opportunity to just like to meet those people and realize that, you know, they'll teach you in any moment and then develop relationships too.

Ben Courchia MD (15:53.046)

Mm-hmm.

Jay Greenspan (15:56.844)

Yeah.

Ben Courchia MD (16:08.192)

Yeah, that's what a key statement you're making. I think we don't realize how humble these people are and how willing they are to collaborate, to teach, to mentor. And so I think it's always so surprising that they would allocate some of their precious time to talk to us, to mentor us, to give us guidance. And I think that's priceless.

I know you're reluctant, Yari, but I want to bring you in a little bit. And I'm wondering if you could share with us a little bit some of the logistics of the conference and for the people who are really now amped up and are saying, all right, I want to go. Can you tell us a little bit about the location? What are some of the highlights of where the conference is taking place this year? And is there anything people should know when it comes to registration in terms of timeline and so on? And maybe if there's any discounts in terms of...

lodging or anything like that that you guys have secured for the attendees, that'd be very helpful.

Yari (17:02.424)

So we'll be at the Gaylord National this year in December. The hotel and registration deadline is coming up November 11th, but we are looking to extend that. Let's see, what else can I say? I know we have some surprises this year that I'm excited about for the in-person attendees, and we are some surprises that even the committee doesn't know about that we're upgrading.

Ben Courchia MD (17:27.916)

Kevin Dysart (17:29.956)

I'm excited now.

Yari (17:31.032)

and just trying to enhance the experience for our attendees. They really help make the event along with the faculty and we want them to feel appreciated and valued and want them to walk away with valuable experience that they can go back and share with their team.

Ben Courchia MD (17:31.168)

Hahaha!

Jay Greenspan (17:31.182)

you

Ben Courchia MD (17:36.769)

for sure.

Ben Courchia MD (17:51.254)

For sure. And I think the team has been extremely responsive in terms of if you have any question, I you guys, I think I know that there's not that many of you, but it feels like there's a ton of you. And that's just a testament to how well you're running this conference because you are extremely responsive. If there's any question, there's a lot of information on the site, but you guys are very much approachable.

Yari (18:11.296)

Yes, we have a full team at Amor, so I can definitely not do it alone. mean, we've got over 60 faculty. I think sometimes they forget that there's one of me to remember every one of their details. But I do love working with everybody.

Ben Courchia MD (18:15.849)

huh.

Ben Courchia MD (18:23.743)

Yeah.

Yeah, for sure. As we're getting to the later half of our interview, I wanted to maybe touch on the few themes that to me are coming up in the agenda and some of the areas that are really going to take center stage at Hot Topics. think there's a significant number of talks that are going to be focusing on BPD. Some of the issues of BPD that a lot of us are struggling with, there's some things that are

are very interesting, I must say. So for example, there's lectures on the benefits of azithromycin therapy. It's something that we've all heard talk about, especially considering the incidence of Ureaplasma infection in mothers in prematurity and the association with BPD, I think. And there's been some data that has come out. So I think it's a great opportunity for people who are interested in that. Thébaud, who we know quite well, who's been on the French podcast, is going to talk about cell-based therapies for BPD. And I know he has a ton of amazing data.

to share with the audience. And then there's a whole session on long volumes and setting peep levels, which I think that will be very well attended.

Jay Greenspan (19:33.55)

You know, we have, we, you know, there's so many opportunities. So this year we're a little lighter on international. We've been heavier in international before in terms of those topics. And we talk about how exciting they have been. This year, we just, it just seemed like there were a lot of studies on chronic lung disease and it's sort of following along with the efforts of the 22, 23 weekers that, you know, that now they're ending up surviving. Thanks to a lot of the strong work from those, you know, the tiny baby programs that you've, you've highlighted.

on your podcast and now we're dealing with the chronic lung disease aspects of it. And so we have to really hone in on, you know, what is best practice? You know, where does Lasix fall? Where does PEEP fall on our treatment protocols? And so we're really excited about that. You know, by the way, caffeine is also mentioned a lot. It's sort of in that same group. And so, you know, it's kind of funny because I was talking to, so Richard Martin, I mean, who better? He's going to be leading that session and, know,

Ben Courchia MD (20:31.074)

recent development on an old drug, caffeine in 2024. I love that. I love that.

Jay Greenspan (20:33.422)

Yeah. And, you know, we have, I was talking to Eric Eichenwald, who's, going to be talking about the MOCA trial and then the ICAP trial. And then he said, and then Barbara's just going to correct us all. So, you know.

Kevin Dysart (20:35.19)

Yeah, yeah, I'm excited to hear like

Ben Courchia MD (20:46.946)

That's correct. That's right. And Barbara Schmidt is actually closing up that session, but it's so interesting because I think this is such a needed discussion. The therapeutic creep when it comes to caffeine has gone out of hand. And when you speak to Barbara Schmidt about it and we discuss the original trials, you get a sense of how far we've pushed this without much evidence. it's nuts. So I'm looking forward to that one as well.

Jay Greenspan (21:01.39)

Crazy.

Jay Greenspan (21:10.125)

Yes.

Kevin Dysart (21:14.148)

Yeah, me too. That was what I was going to highlight. I'm really looking forward to, know, Eric, Carl, and then Barbara. Like, and maybe by the end I'll know what to do.

Jay Greenspan (21:19.745)

Thank you.

Thank you.

Ben Courchia MD (21:22.89)

Yeah, it's very frustrating when the Barbara Schmidts of the world tell you all the things we don't know. like, you're supposed to tell me all these things. That's exactly right. But that's something that was kind of striking to me, especially when conferences are spanning several days. So I was looking at the agenda on Wednesday, and sometimes conferences mid-window down on the last day.

Jay Greenspan (21:31.074)

Yeah.

Kevin Dysart (21:34.148)

The older I get, the less I know.

Ben Courchia MD (21:51.702)

But the last session, mean, first of all, the last day we talked about caffeine, but the last session of that day in search of Goldilocks oxygen management during delivery room resuscitation for preterm infants with Liz Foglia as moderator and the likes of Ola Didrik Saugstad in the speaker panels. mean, it is so exciting. mean, I think for the people who are planning their trip to Hot Topics, this is not a conference where you want to skip on the last day. I mean, I think you want to stay until the very last moment.

Jay Greenspan (22:20.195)

And it's purposeful, obviously, but Liz is just a superstar. she got together that, I mean, this is her session and she's internationally known for her great work in the resuscitation area. So we always have a resuscitation session. And I think we might change how we use oxygen after that session. We'll see. Liz is cautious about making final recommendations, but it should stir us up. And that area of resuscitation, thanks to people like her,

Ben Courchia MD (22:21.642)

Of course.

Jay Greenspan (22:48.27)

has really developed. And I think we've done a lot of good for babies because of that work. so we want to, you know, that's what we all do. We all do this. And if you're a neonatologist or practitioner of neonatology, you got to know how to resuscitate a baby. And she's trying to help us all figure that out. So it's going to be a great closing session.

Ben Courchia MD (23:08.384)

Yeah, yeah, I agree. again, stellar, stellar individuals there. Dr. Ola Didrik Saugstad being one of them. We talked about Dr. Foglia and closing up is Peter Dargaville, who has done such amazing work when it comes to oxygen titration and surfactant and so on and so forth. And it is a topic that has seen quite a few publications in recent years. So there's definitely movement on that front. It is not really trying to beat that horse, so to speak.

Is there any thoughts or anything you would like to share with the audience as we wrap up this teaser episode for Hot Topics 2024? Jay, anything you want to share before we conclude?

Jay Greenspan (23:49.358)

Yeah, think, you know, Kevin and I talk about this all the time is, you know, the international flavor is really important for us because they practice medicine differently in internationally than we do. First off, just as I've alluded to, you know, we used to bring on, you know, the international talks and out of Africa, you know, third world countries about, know, how we do and what can we do better. But they've brought us in last couple of years, some innovative ideas that have worked so well for them that we're now.

know, aspirin, you know, to prevent preterm birth, kangaroo care that we're trying to like, you know, imitate how they've done it because it seems to do better than what we have. And so to be open-minded and look at, know, we're not so great in the United States that we can't learn from, you know, certainly Japan and Sweden and tiny baby programs have been, you know, outpacing us. But the other thing is that we've, you know, we've learned that they just practice medicine differently.

A few years back, Aaron Jensen, our friend who's been on the podcast, think, I think Eric's been on.

Ben Courchia MD (24:52.352)

Yeah, he was one of the first few episodes, one of my big gets in the very early days of the podcast.

Jay Greenspan (24:55.38)

Okay. Yeah. So besides BPD, he's also done stuff on Carsey and he did a survey, he did a survey with Hot Topics and basically the Europeans and Canadians were like, what are you still doing that test? You know, so, so, you know, to hear that, and of course the United States, just do that almost all the time, not everywhere, but, know, to see how they, you know, how they, how they change us, they make us better.

Ben Courchia MD (25:03.018)

I love that paper. I love that paper.

Jay Greenspan (25:23.618)

Kevin talks about some studies that were done in cooling, I think it was, that looked like it didn't work as well elsewhere. And I think in the future, and Rich Poland is going to be talking about antibiotic use, but I think we just, even with the work of people like Karen Pueblo and others to reduce our use of antibiotics, I think they'd do better in Europe of not using as many antibiotics. And we're just using it too much and probably the consequences of that.

are significant. I think, know, Rich is trying to get to that and I think our European colleagues in particular will help us do better.

Ben Courchia MD (26:02.996)

It's so interesting how the constraints of each individual setting, would say, it is folks in Africa, folks in Europe, will lead them to practice in a certain manner that may lead to innovation. think, like you mentioned, Kangaroo Mother Care is a typical example where I think if everybody had very modern incubators, we would have probably shoved these babies in an incubator. And it turns out that the absence of this technology has led to babies being on their mother's chest. And now it has done this sort of disruptive form of innovation where now it has invaded even the

Jay Greenspan (26:13.229)

Yes.

Jay Greenspan (26:20.718)

Nothing.

Ben Courchia MD (26:32.768)

the most high tech units in the world where despite all the cool gadgets we have, putting the baby on the mother's chest is the gold standard. I think that to me is the coolest aspect of us being able to learn from one another irrespective of the resources of our counterparts. Yeah.

Jay Greenspan (26:47.662)

Right? That's right. was an international talk about there was a special oil that they were using out of Stanford in Africa because they didn't have humidity in the incubators and they had to help the skin. We all need to help the skin in kids that are preterm, especially those 22, 24, 25-weekers. And maybe that'll spread and scale to us because they've had to be innovative to help babies in Africa. So we're excited about that connection too.

Ben Courchia MD (27:09.458)

Mm-hmm. Yeah.

Ben Courchia MD (27:15.458)

Thank you, Jay. Kevin, anything to add?

Kevin Dysart (27:18.292)

No, I was going to just let Yari correct me if I go wrong, but I think a half of our attendees are from North America and the other half are international. She's shaking her hand. She's saying yes to us. So that's great. And that's one of my favorite parts about it. Like just to have not just the research they bring, but also being together in that space, a thousand people, half from around the world and getting a chance to learn from people from everywhere.

Ben Courchia MD (27:27.19)

That's Super.

Ben Courchia MD (27:44.386)

So I have to mention this because as we wrap up, would be fitting to mention Jerry Lucey again. And in terms of his work with Bill Rubin started by having one of his fellows translate the Spanish papers into English to learn what they were doing with phototherapy in Latin America. And so I think this is coming back full circle about trying to collaborate and learn from one another. I think that is pretty poetic. Yari, anything to leave us with as we wrap up the episode?

Yari (28:11.948)

Well, I am excited to be celebrating 44 years this year, actually, for Hot Topics. And then I know we want to offer a special incubator podcast listener discount code for 10 % off. So don't know how we kind of share that with the listeners.

Ben Courchia MD (28:16.982)

Congratulations.

Ben Courchia MD (28:28.386)

Absolutely. I think we can definitely put that in the show notes so that people can have a discount on their registration and we'll put all the information in the show notes for people to use. I don't want to say anything on the air. I don't want to give the wrong code, but we'll put that in the description. This way it's clear. Thank you for reminding me.

Yari (28:52.426)

No, no problem. Thank you so much. And I can't wait. Anyone is listening, please say hi to us on sites, you know, put it, you know, so we can know who's listening.

Ben Courchia MD (28:58.112)

Yeah.

Yeah, absolutely. Well, thank you all very much for taking the time. It was a pleasure and see you in December at Hot Topics.

Kevin Dysart (29:09.264)

Yeah, look forward to seeing you in Thank you.

Ben Courchia MD (29:10.807)

Yeah, same.

Jay Greenspan (29:11.502)

Thanks so much, Ben, and thanks, Daphne, wherever you are, when you're playing somewhere. But we really appreciate all you do,

Ben Courchia MD (29:14.818)

Appreciate it.